Quick Answer
BIOTRICITY INC. reported Diluted EPS of $0.56 per share (loss) for fiscal year 2025.
BIOTRICITY INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.56 | +66.6% |
| 2024 | -$1.66 | +26.4% |
| 2023 | -$2.26 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.04 | +22.2% | -44.8% |
| September 30, 2025 | -$0.03 | +60.3% | +0.0% |
| June 30, 2025 | -$0.03 | +94.1% | +46.3% |
| December 31, 2024 | -$0.05 | +84.1% | +26.0% |
| September 30, 2024 | -$0.07 | +83.4% | +85.1% |
| June 30, 2024 | -$0.49 | -19.2% | -44.5% |
| December 31, 2023 | -$0.34 | +37.9% | +23.1% |
| September 30, 2023 | -$0.44 | +22.2% | -7.3% |
- BIOTRICITY INC. showed an increase of +66.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, BIOTRICITY INC.’s diluted eps has grown by 75.4% (from $2.26 per share (loss) to $0.56 per share (loss)).
- The most recent figure is from BIOTRICITY INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: